- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02330809
Drinking Extra Water for to Prevent or Decrease Headaches
Drinking Extra Water To Prevent or Decrease Headaches - A Feasibility Online Randomized Controlled Trial With Adult Participants
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
If participants decide to participate in this trial, they will be asked to drink a specific amount of water at particular times of the day for 14 days. A computer will decide by chance the amount of water they will be asked to drink each day of the trial and the times at which to drink this.
There are different amounts and different times that people will be asked to drink water, this is so that the investigators can find out if there is an optimal volume of water to drink, and a best time to drink water to reduce headaches or hunger. The least amount of water the computer could ask participants to drink is half a glass (that is 4oz or 120ml). The largest volume of water the computer could ask participants to drink would be eight glasses of water a day (a total of 64oz or 2L) spread across the day (that is not all at once). Once the computer has assigned participants to a particular volume and times to drink water, these will remain the same for every day throughout the study.
Participants will be asked to provide some brief information about themselves at the beginning of the study (for example, age, sex, height and whether you exercise, smoke or not). During the study they will be asked to weigh themselves and record this, Their dietary habits and the amount they drink will be kept on a private and confidential page on the study website. They will be asked to fill in [2] confidential short surveys about how they feel and their views, one at the start and one at the end of the study.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oxfordshire
-
Oxford, Oxfordshire, United Kingdom, OX4 4DN
- ThinkWell
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Any adult (defined as someone aged 18 or above) for whom advice to drink extra water is not contraindicated.
Exclusion Criteria
General exclusions
- < 18 years of age
- No personal email address
- Pregnancy
- Ecstasy recreational drug use
Exclusions Health Conditions
- Impaired renal function
- Chronic bowel problems
- Low sodium levels
- Diabetes insipidus
- Schizophrenia or history of psychosis
- Anorexia or bulimia
- Congestive heart failure
- Current chemotherapy treatment
Exclusions Concurrent Medications
- Taking regular non-steroidal anti-inflammatory drugs
- Diuretics (e.g. thiazides, indapamide, loop diuretics), also called "water tablets"
- Anti-depressants: Selective serotonin re-uptake inhibitors (SSRIs), Tricyclic and tetracyclic antidepressants (TCAs),monoamine oxidase inhibitor (MAOIs)
- Anti-psychotics (e.g. haloperidol)
- Anti-convulsants (e.g. sodium valproate, carbamazepine)
- Cancer drugs (anti-neoplastic agents)
Implicit exclusions
- People without internet access
- People who cannot read
- People without the ability to understand the website and informed consent documents
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Daily extra water intake 2L
Timing of daily extra water intake intervention-A: extra water intake: 8 8oz glasses of water a day (2L) - 2 first thing in the morning before breakfast, 2 before midday or midday meal, 2 before afternoon meal and 2 before evening meal. Intervention-B: Drink extra water at anytime over 24 hours |
Amount of extra daily water intake to consume
Intervention-A: Timing of daily extra water intake specified Intervention-B: at any time during 24 hour period
|
Experimental: Daily extra water intake 1L
Timing of daily extra water intake Intervention-A: 4 8oz glasses of water a day (1L) - 1 first thing in the morning before breakfast, 1 before midday or midday meal, 1 before afternoon meal and 1 before evening meal. Intervention-B: Drink extra water at anytime over 24 hours |
Amount of extra daily water intake to consume
Intervention-A: Timing of daily extra water intake specified Intervention-B: at any time during 24 hour period
|
Experimental: Daily extra water intake 500ml
Timing of daily extra water intake Intervention-A: 2 8oz glasses of water a day (500ml) - each half an hour before a meals Intervention-B: Drink extra water at anytime over 24 hours |
Amount of extra daily water intake to consume
Intervention-A: Timing of daily extra water intake specified Intervention-B: at any time during 24 hour period
|
Experimental: Daily extra water intake 120ml
Timing of daily extra water intake Intervention-A: 1/2 a glass of water on waking (120ml). If you forget to drink your water first thing, do not drink it later in the day, just skip this day and drink ½ a glass the next day on waking. Intervention-B: Drink extra water at anytime over 24 hours |
Amount of extra daily water intake to consume
Intervention-A: Timing of daily extra water intake specified Intervention-B: at any time during 24 hour period
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of headache frequency/intensity
Time Frame: Daily for 14 days
|
Online participant reported visual analog scales
|
Daily for 14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hunger
Time Frame: Daily for 14 days
|
Online participant reported Visual analog scales
|
Daily for 14 days
|
Mood Questionnaire
Time Frame: Daily for 14 days
|
Mood will be measured online using happy, sad, neutral faces
|
Daily for 14 days
|
Body mass index (BMI)
Time Frame: Baseline and day 14
|
Participants will use an automated online BMI calculator
|
Baseline and day 14
|
Wellbeing
Time Frame: Baseline and day 14
|
Patient Reported Outcome Measurement Information System (PROMIS) will be used to measure patient-reported outcome (PRO) for answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function.
|
Baseline and day 14
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Amy I Price, PhD, University of Oxford
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ThinkWell-PLOT-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Headache
-
Canadian Memorial Chiropractic CollegeDr. Zaxx Co.UnknownMigraine Headache | Cervicogenic Headache | Tension-type HeadacheCanada
-
University GhentRecruitingTension-Type Headache | Cervicogenic Headache | Myofascial HeadacheBelgium
-
Real Centro Universitario Maria CristinaRecruiting
-
Brooke Army Medical CenterThe University of Queensland; The Defense and Veterans Brain Injury CenterRecruitingHeadache, Migraine | Persistent Post Traumatic Headache | Cervicogenic HeadacheUnited States
-
Uniformed Services University of the Health SciencesNational Institutes of Health (NIH); University of North Carolina, Chapel Hill and other collaboratorsRecruitingPost-Traumatic Headache Chronic Without Intractable HeadacheUnited States
-
University of WashingtonTerminatedChronic Post Traumatic HeadacheUnited States
-
University of AlbertaCompletedChronic Headache | Chronic Daily Headache | Analgesic Rebound Headache | Headache, IntractableCanada
-
University Hospital, GhentRecruitingMigraine Disorders | Headache Disorders | Tension-Type Headache | Cluster Headache | TACS | Secondary Headache DisorderBelgium
-
Meltem UzunCompletedExercise | Therapeutics | Headache, CervicogenicTurkey
-
Hospital of South West JutlandCompletedMedication-overuse Headache | Secondary Headache Disorders
Clinical Trials on Daily extra water intake
-
ThinkWellWithdrawnObesity | Dietary ModificationUnited Kingdom
-
Virginia Polytechnic Institute and State UniversityRecruiting
-
Hospital de Clinicas de Porto AlegreActive, not recruitingRenal Function DisorderBrazil
-
University of Illinois at Urbana-ChampaignDivision of Nutritional Sciences, University of Illinois at Urbana-ChampaignCompletedCognitive Change | Dehydration | Gastrointestinal MicrobiotaUnited States
-
Loughborough UniversityCompletedHypohydrated | EuhydratedUnited Kingdom
-
George Mason UniversityCompletedHydration and Resting Metabolism
-
University of Illinois at Urbana-ChampaignDanone ResearchCompletedLow Fluid Intake, ChronicUnited States
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompletedAutosomal Dominant Polycystic KidneyUnited States
-
Riphah International UniversityCompleted